Zobrazeno 1 - 10
of 172
pro vyhledávání: '"J, García Laraña"'
Autor:
L, Suárez, B, Vidriales, J, García-Laraña, A, López, R, Martínez, V, Martín-Reina, M, Tormo, J D, González-San Miguel, E, Lavilla, R, García-Boyero, A, Orfao, J F, San Miguel
Publikováno v:
Haematologica. 86(12)
Acute myeloid leukemia (AML) is a heterogeneous group of malignant diseases, often characterized by coexistence of more than one subpopulation of blast cells. Multiparametric flow cytometry immunophenotyping has proven to be a reliable and sensitive
Autor:
J J, Lahuerta, J, Martinez-Lopez, J D, Serna, J, Bladé, C, Grande, A, Alegre, L, Vazquez, J, García-Laraña, A, Sureda, J D, Rubia, E, Conde, R, Martinez, K, Perez-Equiza, J M, Moraleda, A, León, J, Besalduch, R, Cabrera, J D, Miguel, A, Morales, J C, García-Ruíz, J, Diaz-Mediavilla, J, San-Miguel
Publikováno v:
British journal of haematology. 109(2)
We have retrospectively analysed 344 multiple myeloma (MM) patients (202 de novo patients) treated in a non-uniform way in whom high-dose therapy and autologous stem cell transplantation (ASCT) response was simultaneously measured by both electrophor
Autor:
J J, Lahuerta, J, Martinez-Lopez, C, Grande, J, Bladé, J, de la Serna, A, Alegre, J, García-Laraña, D, Caballero, A, Sureda, J, de la Rubia, A M, Alvarez, J, Marín, A, Escudero, E, Conde, K, Perez-Equiza, J C, García Ruiz, J M, Moraleda, A, León, J, Bargay, R, Cabrera, M T, Hernandez-García, J, Diaz-Mediavilla, J S, Miguel
Publikováno v:
British journal of haematology. 109(1)
High-dose chemoradiotherapy conditioning regimens for autologous stem cell transplantation (ASCT) are generally held to give similar results in multiple myeloma (MM), but no specific comparative study has been published. We addressed this issue by co
Autor:
J L, Steegmann, J, Odriozola, F, Rodriguez-Salvanés, P, Giraldo, J, García-Laraña, M T, Ferro, E, Benítez, C, Pérez-Pons, M, Giralt, L, Escribano, E, Lavilla, A, Miguel, C, Areal, M, Pérez-Encinas, A, Abad, J, Maldonado, I, Massagué, J M, Fernández-Rañada
Publikováno v:
Haematologica. 84(11)
Interferon-a (IFN) is increasingly being used as the drug of choice in chronic myeloid leukemia patients. The main objectives of the study were to study the influence of the classic prognostic variables and response to IFN, and to assess the influenc
Autor:
J, García Laraña
Publikováno v:
Revista clinica espanola. 199
Autor:
A, Alegre, J, Díaz-Mediavilla, J, San-Miguel, R, Martínez, J, García Laraña, A, Sureda, J J, Lahuerta, D, Morales, J, Bladé, D, Caballero, J, De la Rubia, A, Escudero, J L, Díez-Martín, F, Hernández-Navarro, J, Rifón, J, Odriozola, S, Brunet, J, De la Serna, J, Besalduch, M J, Vidal, C, Solano, A, Leon, J J, Sánchez, C, Martínez-Chamorro, J M, Fernández-Rañada
Publikováno v:
Bone marrow transplantation. 21(2)
Between January 1989 and November 1995, 259 patients with multiple myeloma (MM), 22 stage I, 57 stage II and 180 stage III at diagnosis were treated with myeloablative high-dose therapy followed by autologous peripheral blood stem cell (PBSC) transpl
Autor:
M, Resino, M T, Ferro, J, García-Laraña, J M, García-Sagredo, P, Cabello, A, López-Yarto, C, San Román
Publikováno v:
Sangre. 39(6)
We report a patient with chronic myelocytic leukaemia (CML) in blastic crisis with a del (7) (p11 p15) in addition to the Philadelphia chromosome. A potential relationship between the presence of this deletion and the therapy in chronic phase is sugg
Publikováno v:
Medicina clinica. 103(10)
The diagnosis of cerebral toxoplasmosis in an immunosuppressed patient is based on computer tomography (CT) findings and response to specific empiric treatment. Although infrequent, cerebral toxoplasmosis has been described in patients undergoing bon
Autor:
E, Conde, J, Sierra, A, Iriondo, A, Domingo, J, García Laraña, J, Marín, D, Caballero, F, Martínez, A, León, J, García-Conde
Publikováno v:
Bone marrow transplantation. 14(2)
One hundred and four patients with low grade (9 patients), intermediate grade (31 patients) and high grade (64 patients) non-Hodgkin's lymphoma received an autologous bone marrow transplantation (BMT). Disease status at transplant was first complete
Autor:
J. García Laraña, Juan F. Navarro, Julio Pascual, R. García González, Joaquín Ortuño, Fernando Liaño
Publikováno v:
Nephrology Dialysis Transplantation.